BRIEF-Hope Therapeutics And Nrx Pharma Announce Signing Of A Term Sheet For Strategic Investment From A Global Medical Device Manufacturer

Reuters

Apr 03

BRIEF-Hope <a href="https://laohu8.com/S/LENZ">Therapeutics</a> And Nrx Pharma Announce Signing Of A Term Sheet For Strategic Investment From A Global Medical Device Manufacturer

April 3 (Reuters) - NRX Pharmaceuticals Inc NRXP.O:

HOPE THERAPEUTICS, INC. AND NRX PHARMACEUTICALS, INC. $(NRXP)$ ANNOUNCE SIGNING OF A TERM SHEET FOR STRATEGIC INVESTMENT FROM A GLOBAL MEDICAL DEVICE MANUFACTURER INTO HOPE
NRX: TERM SHEET CONTEMPLATES INVESTMENT OF $2.5 MILLION TO BUY SERIES A CONVERTIBLE PREFERRED STOCK AT $50 MILLION PRE-MONEY VALUATION

Source text: ID:nPn9KZg4xa

Further company coverage: NRXP.O

(((( Reuters.briefs@thomsonreuters.com ;));))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2524425969"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2524425969\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2524425969?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-03 20:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2524425969","market":"nz","top_or_hot":-1,"title":"BRIEF-Hope Therapeutics And Nrx Pharma Announce Signing Of A Term Sheet For Strategic Investment From A Global Medical Device Manufacturer","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Hope <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> And Nrx Pharma Announce Signing Of A Term Sheet For Strategic Investment From A Global Medical Device Manufacturer</title></head><body><p><span>April 3 (Reuters)</span><span> - </span>NRX Pharmaceuticals Inc <span>NRXP.O</span>:</p><ul><li><p>HOPE THERAPEUTICS, INC. AND NRX PHARMACEUTICALS, INC. <a href=\"https://laohu8.com/S/NRXP\">$(NRXP)$</a> ANNOUNCE SIGNING OF A TERM SHEET FOR STRATEGIC INVESTMENT FROM A GLOBAL MEDICAL DEVICE MANUFACTURER INTO HOPE</p></li><li><p>NRX: TERM SHEET CONTEMPLATES INVESTMENT OF $2.5 MILLION TO BUY SERIES A CONVERTIBLE PREFERRED STOCK AT $50 MILLION PRE-MONEY VALUATION</p></li></ul><p>Source text: <span>ID:nPn9KZg4xa</span></p><p>Further company coverage: <span>NRXP.O</span></p><p> (((( Reuters.briefs@thomsonreuters.com ;));))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Hope Therapeutics And Nrx Pharma Announce Signing Of A Term Sheet For Strategic Investment From A Global Medical Device Manufacturer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Hope Therapeutics And Nrx Pharma Announce Signing Of A Term Sheet For Strategic Investment From A Global Medical Device Manufacturer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-04-03 20:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Hope <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> And Nrx Pharma Announce Signing Of A Term Sheet For Strategic Investment From A Global Medical Device Manufacturer</title></head><body><p><span>April 3 (Reuters)</span><span> - </span>NRX Pharmaceuticals Inc <span>NRXP.O</span>:</p><ul><li><p>HOPE THERAPEUTICS, INC. AND NRX PHARMACEUTICALS, INC. <a href=\"https://laohu8.com/S/NRXP\">$(NRXP)$</a> ANNOUNCE SIGNING OF A TERM SHEET FOR STRATEGIC INVESTMENT FROM A GLOBAL MEDICAL DEVICE MANUFACTURER INTO HOPE</p></li><li><p>NRX: TERM SHEET CONTEMPLATES INVESTMENT OF $2.5 MILLION TO BUY SERIES A CONVERTIBLE PREFERRED STOCK AT $50 MILLION PRE-MONEY VALUATION</p></li></ul><p>Source text: <span>ID:nPn9KZg4xa</span></p><p>Further company coverage: <span>NRXP.O</span></p><p> (((( Reuters.briefs@thomsonreuters.com ;));))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250403:nFWN3QH0DJ:1","article_id":"2524425969","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2524425969","pubTimestamp":1743682948,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Hope Therapeutics And Nrx Pharma Announce Signing Of A Term Sheet For Strategic Investment From A Global Medical Device ManufacturerApril 3 (Reuters) - NRX Pharmaceuticals Inc NRXP.O:HOPE THERAP","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","NRXP":"NRX Pharmaceuticals Inc."},"translate_title":"简报-Hope Therapeutics和Nrx Pharma宣布签署全球医疗器械制造商战略投资条款清单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NRXP":0.9},"content_text":"BRIEF-Hope Therapeutics And Nrx Pharma Announce Signing Of A Term Sheet For Strategic Investment From A Global Medical Device ManufacturerApril 3 (Reuters) - NRX Pharmaceuticals Inc NRXP.O:HOPE THERAPEUTICS, INC. AND NRX PHARMACEUTICALS, INC. $(NRXP)$ ANNOUNCE SIGNING OF A TERM SHEET FOR STRATEGIC INVESTMENT FROM A GLOBAL MEDICAL DEVICE MANUFACTURER INTO HOPENRX: TERM SHEET CONTEMPLATES INVESTMENT OF $2.5 MILLION TO BUY SERIES A CONVERTIBLE PREFERRED STOCK AT $50 MILLION PRE-MONEY VALUATIONSource text: ID:nPn9KZg4xaFurther company coverage: NRXP.O (((( Reuters.briefs@thomsonreuters.com ;));))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}